| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/02/2007 | US7157453 Urea substituted imidazoquinolines |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | CA2290538C Composition comprising finely divided, crystalline particles of budesonide |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 12/28/2006 | WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/28/2006 | WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137790A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137789A1 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 12/28/2006 | WO2006137423A1 Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli |
| 12/28/2006 | WO2006137421A1 Agent for topical administration |
| 12/28/2006 | WO2006136857A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 12/28/2006 | WO2006136563A1 2-substituted benzimidazoles |
| 12/28/2006 | WO2006136562A1 Heterocyclylaminoalkyl substituted benzimidazoles |
| 12/28/2006 | WO2006136561A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 12/28/2006 | WO2006136448A2 Attenuated sars and use as a vaccine |
| 12/28/2006 | WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 12/28/2006 | WO2006136304A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 12/28/2006 | WO2006136084A1 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 12/28/2006 | WO2006125132A3 Aerosolized fluoroquinolones and uses thereof |
| 12/28/2006 | WO2006117299A9 Novel crystalline forms of tiotropium bromide |
| 12/28/2006 | WO2006117299A2 Novel crystalline forms of tiotropium bromide |
| 12/28/2006 | WO2006105222A3 Carboxamide inhibitors of tgfb |
| 12/28/2006 | WO2006087419A3 A method for administering levosimendan |
| 12/28/2006 | WO2006031191A8 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 12/28/2006 | WO2005094796A3 Methods for interfering with fibrosis |
| 12/28/2006 | US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 12/28/2006 | US20060293352 Phenoxiacetic acid derivatives |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293293 Salmeterol and ciclesonide combination |
| 12/28/2006 | US20060293275 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060293221 Mucosal repair by TFF2 peptides |
| 12/28/2006 | US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases |
| 12/28/2006 | US20060292085 Medicaments |
| 12/28/2006 | DE102005028845A1 New substituted pyrrolidin-2-ones, piperidin-2-ones and isothiazolidine-1,1-dioxides useful for treating e.g. dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, breast cancer and heart failure |
| 12/28/2006 | CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof |
| 12/28/2006 | CA2613001A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators |
| 12/28/2006 | CA2612922A1 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 12/28/2006 | CA2612646A1 Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract |
| 12/28/2006 | CA2612265A1 2-substituted benzimidazoles |
| 12/28/2006 | CA2612264A1 Heterocyclylaminoalkyl substituted benzimidazoles |
| 12/28/2006 | CA2612263A1 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 12/28/2006 | CA2612133A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | CA2610773A1 Clarithromycin or a salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli |
| 12/28/2006 | CA2610326A1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1.5 potassium channel blockers and pharmaceutical preparations comprising them |
| 12/28/2006 | CA2610075A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 12/27/2006 | EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof |
| 12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
| 12/27/2006 | EP1736539A1 Attenuated SARS-CoV vaccines |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1736168A1 Protease inhibitor and preventives or remedies for diseases |
| 12/27/2006 | EP1736161A2 Use of an arsenic compound for the manufacture of a medicament for the treatment of arsenic susceptible blast-like cell related diseases |
| 12/27/2006 | EP1736153A2 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd) |
| 12/27/2006 | EP1736147A2 Non-chlorofluorocarbon aerosol formulations |
| 12/27/2006 | EP1735298A1 Piperidine derivates for the treatment of chemokines mediared disease |
| 12/27/2006 | EP1735007A2 Cyclodextrin inclusion complexes of pyrimidine-2,4,6-triones |
| 12/27/2006 | EP1734987A2 Interferon-beta for anti-virus therapy for respiratory diseases |
| 12/27/2006 | EP1734976A1 Extracts of scutellaria for the treatment of sars |
| 12/27/2006 | EP1734956A1 Treatment of impaired respiratory function with gaboxadol |
| 12/27/2006 | EP1734952A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 12/27/2006 | EP1660476B1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| 12/27/2006 | EP1554303B1 Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester |
| 12/27/2006 | EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1429843B1 Combination of a pde inhibitor and a leukotriene receptor antagonist |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1368317B1 Tryptase inhibitors |
| 12/27/2006 | EP1354047B1 Methods for screening compounds that modulate lipid metabolism |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/27/2006 | EP1105505B1 Compound and method for the prevention and/or the treatment of allergy |
| 12/27/2006 | CN1886506A Protein expressed in nk cell |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 12/27/2006 | CN1886147A Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 12/27/2006 | CN1886139A Soft steroid compositions for use in dry powder inhalers |
| 12/27/2006 | CN1884302A Staphylococcus aureus fusion protein of fibronectin and bindin, its preparation method and uses |
| 12/27/2006 | CN1883679A Medicine for treating pulmonary tuberculosis |
| 12/27/2006 | CN1883678A Medicine for treating infants cough and preparation method thereof |
| 12/27/2006 | CN1883676A Preparation for treating rhinitis |
| 12/27/2006 | CN1883664A Medicine for treating acute tracheitis |
| 12/27/2006 | CN1883663A Pure Chinese medicine for treating chronic rhinitis, pharyngitis and globus hysterics |
| 12/27/2006 | CN1883651A Chinese medicinal composition for treating wind-heat cold and preparation method thereof |
| 12/27/2006 | CN1883632A Preparation method of Chinese medicine for treating cough induced by cold and Chinese medicine prepared thereby |
| 12/27/2006 | CN1883624A Medicine for treating chronic rhinitis and nasal sinusitis and method for preparing same |
| 12/27/2006 | CN1883605A Vinegar capable of improving cerebral function |
| 12/27/2006 | CN1883601A Chinese medicinal capsule for treating inflammation and method for preparing same |